In addition , there was a trend toward reduced hematological toxicity among patients with variants of SLC@A@ G@A in treatment arm @ ( P for trend , @ ) and reduced esophagitis/stomatitis noted among patients with variants of TSER in treatment arm @ ( P for trend , @ ) .